Table 1.

Descriptions of the 10 patients with proven or probable invasive aspergillosis showing the site involved, underlying condition, antifungal treatment received, and outcome

Yr	Clinical form	Underlying condition	Diagnosis	Antifungal treatment	Outcome	Patient with mutant isolatesb
2001	Pericarditis and adenopathies	HIV	Proven	Amphotericin B	Poor	D
2001	Pulmonary	Hematological cancer	Probable	Amphotericin B	Poor	E
2002	Postsurgical	Surgery	Probable	Itraconazole	Survival
2002	Pulmonary	COPDa	Probable	Amphotericin B	Poor
2003	Postsurgical	Surgery	Probable	Itraconazole	Survival
2003	Pulmonary	COPD	Probable	Caspofungin	Poor
2006	Postsurgical mediastinitis	Surgery	Proven	Voriconazole + caspofungin	Poor	B
2006	Pulmonary	COPD	Probable	Voriconazole	Survival
2007	Pulmonary	COPD	Probable	Voriconazole	Survival
2007	Pulmonary	COPD	Probable	Voriconazole	Survival

^aCOPD, chronic obstructive pulmonary disease.

^bPatients infected with isolates harboring mutations in the cyp51A gene are identified by an alphabetical code.